Review
doi: 10.1016/j.mce.2011.07.005.
Epub 2011 Jul 20.
Activins and activin antagonists in the prostate and prostate cancer
Affiliations
- PMID: 21787836
- DOI: 10.1016/j.mce.2011.07.005
Item in Clipboard
Review
Activins and activin antagonists in the prostate and prostate cancer
Mol Cell Endocrinol.
.
Abstract
Activins are members of the TGF-β super-family. There are 4 mammalian activin subunits (β(A), β(B), β(C) and β(E)) that combine to form functional proteins. The role of activin A (β(A)β(A)) is well characterized and known to be a potent growth and differentiation factor. Two of the activin subunits (β(C) and β(E)) were discovered more recently and little is known about their biological functions. In this review the evidence that activin-β(C) is a significant regulator of activin A bioactivity is presented and discussed. It is concluded that activin-β(C), like other antagonists of activin A, is an important growth regulator in prostate health and disease.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Regulation of prostate branching morphogenesis by activin A and follistatin.Dev Biol. 2001 Sep 1;237(1):145-58. doi: 10.1006/dbio.2001.0364. Dev Biol. 2001. PMID: 11518512
-
Localization of activin beta(A)-, beta(B)-, and beta(C)-subunits in humanprostate and evidence for formation of new activin heterodimers of beta(C)-subunit.J Clin Endocrinol Metab. 2000 Dec;85(12):4851-8. doi: 10.1210/jcem.85.12.7052. J Clin Endocrinol Metab. 2000. PMID: 11134153
-
Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG).Endocrinology. 2003 May;144(5):1671-4. doi: 10.1210/en.2002-0203. Endocrinology. 2003. PMID: 12697670
-
The contribution of inhibins and activins to malignant prostate disease.Mol Cell Endocrinol. 2001 Jun 30;180(1-2):149-53. doi: 10.1016/s0303-7207(01)00497-x. Mol Cell Endocrinol. 2001. PMID: 11451585 Review.
-
Pituitary actions of ligands of the TGF-beta family: activins and inhibins.Reproduction. 2006 Aug;132(2):207-15. doi: 10.1530/rep.1.01073. Reproduction. 2006. PMID: 16885530 Review.
Cited by
-
Intra-epithelial non-canonical Activin A signaling safeguards prostate progenitor quiescence.EMBO Rep. 2022 May 4;23(5):e54049. doi: 10.15252/embr.202154049. Epub 2022 Mar 7. EMBO Rep. 2022. PMID: 35253958 Free PMC article.
-
Integrative characterisation of secreted factors involved in intercellular communication between prostate epithelial or cancer cells and fibroblasts.Mol Oncol. 2023 Mar;17(3):469-486. doi: 10.1002/1878-0261.13376. Epub 2023 Jan 27. Mol Oncol. 2023. PMID: 36608258 Free PMC article.
-
Profiling Activins and Follistatin in Colorectal Cancer According to Clinical Stage, Tumour Sidedness and Smad4 Status.Pathol Oncol Res. 2021 Nov 15;27:1610032. doi: 10.3389/pore.2021.1610032. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34867090 Free PMC article.
-
Activin A expression in esophageal carcinoma and its association with tumor aggressiveness and differentiation.Oncol Lett. 2015 Jul;10(1):143-148. doi: 10.3892/ol.2015.3248. Epub 2015 May 20. Oncol Lett. 2015. PMID: 26170990 Free PMC article.
-
Follistatin as potential therapeutic target in prostate cancer.Target Oncol. 2013 Dec;8(4):215-23. doi: 10.1007/s11523-013-0268-7. Epub 2013 Mar 1. Target Oncol. 2013. PMID: 23456439 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
